People · Operator
Named in public records as an officer, director or promoter · active 2016–2016 · Biotechnology
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| ReCor Medical, Inc. | — | Biotechnology | Series B | $22.0M | $873.2M | 2016 |
Kazumichi M. Kobayashi at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Kazumichi M. Kobayashi on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Martin J. Waters | 1 | 9 |
| Andrew M. Weiss | 1 | 3 |
| Frank M. Litvack | 1 | 2 |
| F. Thomas Watkins | 1 | 2 |
| Jacques M. Seguin | 1 | 1 |
| Antoine M. Papiernik | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.